We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 44
Most popular |Most recent


HHS Secretary Azar Announces DTC Drug Price Transparency Proposal, Foreshadows Additional Regulatory Action to Address Drug Prices

USA - October 16 2018 On October 15, 2018, Secretary of Health and Human Services (HHS) Alex Azar delivered remarks at a National Academy of Medicine event in which he...

Trevor L. Wear, Meenakshi Datta, Stephanie P. Hales.


Oregon Passes Prescription Drug Price Transparency Law

USA - March 22 2018 On March 12, 2018, Oregon Gov. Kate Brown signed into law Oregon House Bill 4005 (HB 4005), joining the growing number of states that have implemented...

Trevor L. Wear, Meenakshi Datta.


California Passes Sweeping Prescription Drug Price Transparency Law and Co-Pay Coupon Ban

USA - October 18 2017 Earlier this month, California passed two bills with significant implications for pharmaceutical manufacturers: one imposing prescription drug price...

Trevor L. Wear, Meenakshi Datta.


OIG Finalizes Long-Awaited Rules on New AKS Safe Harbors and Civil Monetary Penalties

USA - December 19 2016 Earlier this month, the U.S. Office of Inspector General (OIG) finalized two key proposed rules, one related to the Civil Monetary Penalties (CMP)...

Mark B. Langdon, Trevor L. Wear, Meenakshi Datta, Brenna E. Jenny.


New Medicaid Rebate and 340B Agreements; MDRP Implementation Delays

USA - November 17 2016 Several important updates have been issued to the Medicaid Drug Rebate and 340B Drug Pricing Programs in the month of November. Medicaid Drug Rebate...

Trevor L. Wear, Meenakshi Datta, Stephanie P. Hales.